Protein entrapment in PEGylated lipid nanoparticles

Int J Pharm. 2013 Oct 1;454(2):625-32. doi: 10.1016/j.ijpharm.2013.06.006. Epub 2013 Jun 17.

Abstract

Defining appropriate delivery strategies of therapeutic proteins, based on lipid nanoparticulate carriers, requires knowledge of the nanoscale organization that determines the loading and release properties of the nanostructured particles. Nanoencapsulation of three cationic proteins (human brain-derived neurotrophic factor (BDNF), α-chymotrypsinogen A, and histone H3) was investigated using anionic nanoparticle (NP) carriers. PEGylated lipid NPs were prepared from self-assembled liquid crystalline phases involving monoolein and eicosapentaenoic acid. Inclusion of the antioxidant α-tocopherol favoured the preparation of stealth hexosome carriers. The purpose of the present work is to reveal the structural features of the protein-loaded lipid nanocarriers by means of high resolution small-angle X-ray scattering (SAXS) and cryogenic transmission electron microscopy (cryo-TEM). The obtained results indicate that protein entrapment is concentration-dependent and may significantly modify the inner liquid crystalline structure of the lipid nanocarriers through changes in the interfacial curvature and hydration.

Keywords: BDNF; Hexosomes; Neurotrophin; PEGylated liquid crystalline nanocarriers; Protein nanoencapsulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain-Derived Neurotrophic Factor / chemistry*
  • Chymotrypsinogen / chemistry*
  • Histones / chemistry*
  • Lipids / chemistry
  • Microscopy, Electron, Transmission
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Polyethylene Glycols / chemistry
  • Scattering, Small Angle
  • X-Ray Diffraction

Substances

  • Brain-Derived Neurotrophic Factor
  • Histones
  • Lipids
  • Polyethylene Glycols
  • BDNF protein, human
  • Chymotrypsinogen